More than 85% of refractory anemia with ring sideroblast patients (RARS) contains mutations in SF3B1 gene with SF3B1K700E as the most frequent mutation. This evidence concerns the gene SF3B1 and myelodysplastic syndrome with single lineage dysplasia.